Shilin Luo

1.9k total citations
52 papers, 1.3k citations indexed

About

Shilin Luo is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Shilin Luo has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Neurology and 7 papers in Genetics. Recurrent topics in Shilin Luo's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (6 papers) and Tryptophan and brain disorders (4 papers). Shilin Luo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (6 papers) and Tryptophan and brain disorders (4 papers). Shilin Luo collaborates with scholars based in China, United States and Japan. Shilin Luo's co-authors include Daxiong Xiang, Junyong Wu, Si Huang, Xiong-Bin Hu, Xiaojie Zhang, Yongjiang Li, Keqiang Ye, Ji‐chun Zhang, Qianqian Cao and Qi Qi and has published in prestigious journals such as Journal of Neuroscience, FEBS Letters and Journal of Controlled Release.

In The Last Decade

Shilin Luo

42 papers receiving 1.3k citations

Peers

Shilin Luo

PHARM

CMN

Zhiyou Yang China

Hui Su China

Xiaole Wang China

Lang Zhang China

Chunhu Zhang China

Yu Long China

Kai Fan China

Dianfeng Liu China

Pallab Bhattacharya India

Aroona Razzaq Pakistan

Zhiyou Yang China

Shilin Luo

547 ×0.8

111 ×0.7

160 ×1.1

185 ×1.3

PHARM

65 ×0.5

CMN

Citations per year, relative to Shilin Luo Shilin Luo (= 1×) peers Zhiyou Yang

Countries citing papers authored by Shilin Luo

Since Specialization

Citations

This map shows the geographic impact of Shilin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilin Luo more than expected).

Fields of papers citing papers by Shilin Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilin Luo. The network helps show where Shilin Luo may publish in the future.

Co-authorship network of co-authors of Shilin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shilin Luo. A scholar is included among the top collaborators of Shilin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilin Luo. Shilin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuxiang, Jianhua Zhang, Jiwei Zhang, et al.. (2025). A Unified RCS Modeling of Typical Targets for 3GPP ISAC Channel Standardization and Experimental Analysis. IEEE Journal on Selected Areas in Communications. 44. 702–716.

Zhang, Sizhe, Haokun Liu, Qijie Yang, et al.. (2025). Accurate Diagnosis of Alzheimer’s Disease Using Specific Breath Volatile Organic Compounds. ACS Sensors. 10(4). 2699–2711.

Xiao, Xuewen, Hui Liu, Rui Yao, et al.. (2025). LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese. The Journal of Prevention of Alzheimer s Disease. 12(5). 100087–100087.

Luo, Shilin, Jie Chen, Ou Zhang, et al.. (2024). Human umbilical cord-derived mesenchymal stem cells alleviate valproate-induced immune stress and social deficiency in rats. Frontiers in Psychiatry. 15. 1431689–1431689.

Huang, Si, Yongjiang Li, Junyong Wu, et al.. (2024). Biomimetic nanodecoys deliver cholesterol-modified heteroduplex oligonucleotide to target dopaminergic neurons for the treatment of Parkinson's disease. Acta Biomaterialia. 177. 316–331. 6 indexed citations

Luo, Shilin, Jia Jia, Zhibin Guo, et al.. (2023). Identification of major QTLs for soybean seed size and seed weight traits using a RIL population in different environments. Frontiers in Plant Science. 13. 1094112–1094112. 21 indexed citations

Zhang, Xi, et al.. (2023). Primary cilia-associated protein IFT172 in ciliopathies. Frontiers in Cell and Developmental Biology. 11. 1074880–1074880. 3 indexed citations

Xiang, Jie, Yiyuan Xia, Shilin Luo, Zhentao Zhang, & Keqiang Ye. (2023). Protocol for screening α-synuclein PET tracer candidates in vitro and ex vivo. STAR Protocols. 5(1). 102788–102788.

Huang, Si, et al.. (2022). Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity. Frontiers in Pharmacology. 13. 895573–895573. 11 indexed citations

10.

Wu, Junyong, Yongjiang Li, Jiemin Wang, et al.. (2021). Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. Journal of Nanobiotechnology. 19(1). 405–405. 53 indexed citations

11.

Lei, Kecheng, Xiaoxia Gu, Alvaro G. Alvarado, et al.. (2020). Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma. Journal of Hematology & Oncology. 13(1). 141–141. 42 indexed citations

12.

Yang, Jiaolong, Shilin Luo, Jichun Zhang, et al.. (2020). Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease. Neurobiology of Disease. 148. 105218–105218. 112 indexed citations

13.

Liu, Qiang, et al.. (2019). Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway. European Journal of Pharmacology. 858. 172480–172480. 29 indexed citations

14.

Li, Wen‐Qun, Junyong Wu, Daxiong Xiang, et al.. (2019). <p>Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis</p>. International Journal of Nanomedicine. Volume 14. 8345–8360. 76 indexed citations

15.

Luo, Shilin, Seong Su Kang, Xia Liu, et al.. (2019). Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease. Journal of Neuroscience. 39(37). 7291–7305. 56 indexed citations

16.

Zhang, Miao, Lin Guo, Longfei Lin, et al.. (2018). Absorption Characteristics of Combination Medication of Realgar and Indigo Naturalis: In Vitro Transport across MDCK‐MDR1 Cells and In Vivo Pharmacokinetics in Mice after Oral Administration. Evidence-based Complementary and Alternative Medicine. 2018(1). 6493630–6493630. 6 indexed citations

17.

Luo, Shilin, Kecheng Lei, Daxiong Xiang, & Keqiang Ye. (2018). NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2018(1). 9146528–9146528. 41 indexed citations

18.

Yang, Yuwei, Wenqi Wang, Xiaojie Duan, et al.. (2017). The identification of functional proteins from amputated lumbricus Eisenia fetida on the wound healing process. Biomedicine & Pharmacotherapy. 95. 1469–1478. 19 indexed citations

19.

Luo, Shilin, Xiaojie Duan, Zhiqian Zhang, et al.. (2016). A Network Pharmacology Approach to Uncover the Pharmacological Mechanism of XuanHuSuo Powder on Osteoarthritis. Evidence-based Complementary and Alternative Medicine. 2016(1). 3246946–3246946. 45 indexed citations

20.

Luo, Shilin, Xiao‐Jun Huang, Ying Wang, et al.. (2014). Isocoumarins from American cockroach (Periplaneta americana) and their cytotoxic activities. Fitoterapia. 95. 115–120. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact